# Ulthera, Inc clinical trials: 46 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 46 trials with Ulthera, Inc as lead sponsor, 0 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Ulthera, Inc: 46 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/ulthera-inc

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 46
- Recruiting or not yet: 0
- Read on: November 19, 2026

## Trials

The 25 newest of 46, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| July 26, 2018 | NCT03599349 | Evaluation of the Ulthera® System and Efficacy Correlation to Morphological Differences | Ulthera, Inc | Not applicable | Completed | Facial and Neck Skin Laxity | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03599349) |
| June 4, 2018 | NCT03545412 | Clinical Study on the Application of a Non-Invasive Micro-Focused Ultrasound With Visualization System for Skin Laxity (ULT-215) | Ulthera, Inc | Not applicable | Completed | Facial Skin Laxity | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03545412) |
| October 25, 2017 | NCT03320096 | Evaluation of the Ulthera System for Treating Axillary Hyperhidrosis | Ulthera, Inc | Not applicable | Completed | Axillary Hyperhidrosis | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03320096) |
| April 13, 2016 | NCT02736825 | Simulines Non-Inferiority Pivotal Study | Ulthera, Inc | Not applicable | Terminated | Skin Laxity | 262 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02736825) |
| May 14, 2015 | NCT02444169 | Retrospective Evaluation of Combination Treatment With the Ulthera System | Ulthera, Inc | Observational | Completed | Skin Laxity | 101 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02444169) |
| May 12, 2015 | NCT02441036 | Gene Expression Following Ultherapy® Treatment | Ulthera, Inc | Not applicable | Terminated | Skin Laxity | 16 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02441036) |
| April 14, 2015 | NCT02416076 | Ultherapy® for Treating the Face and Neck Using Standard Versus Simulines Transducers | Ulthera, Inc | Not applicable | Completed | Skin Laxity | 42 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02416076) |
| November 10, 2014 | NCT02286804 | Ultherapy for the Treatment of Spider Veins on the Legs | Ulthera, Inc | Not applicable | Completed | Telangiectasia, Spider Veins | 9 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02286804) |
| November 10, 2014 | NCT02286765 | Ulthera® System for Treating Axillary Hyperhidrosis | Ulthera, Inc | Not applicable | Completed | Primary Axillary Hyperhidrosis | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02286765) |
| October 21, 2014 | NCT02270892 | Ultherapy for Buttock Lift | Ulthera, Inc | Not applicable | Completed | Buttock Ptosis | 38 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02270892) |
| May 22, 2014 | NCT02145364 | Ultherapy® for the Treatment of Acne Scars | Ulthera, Inc | Not applicable | Completed | Acne Scars, Atrophic Acne Scars | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02145364) |
| May 21, 2014 | NCT02144181 | Ultherapy® for the Treatment of Erythematotelangiectatic Rosacea | Ulthera, Inc | Not applicable | Completed | Erythematotelangiectatic Rosacea, Rosacea | 88 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02144181) |
| November 11, 2013 | NCT01981252 | Peri-orbital and Peri-oral Wrinkle Reduction Trial | Ulthera, Inc | Not applicable | Terminated | Peri-orbital Wrinkles, Peri-oral Wrinkles | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01981252) |
| June 21, 2013 | NCT01883414 | Feasibility Study: Evaluation of the Ulthera® System for Improvement of Surgical Scars. | Ulthera, Inc | Not applicable | Terminated | Surgical Scar | 14 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01883414) |
| March 13, 2013 | NCT01810484 | Feasibility Study: Evaluation of the Treatment of Striae Using Ultherapy® in Combination With Laser Treatment | Ulthera, Inc | Not applicable | Completed | Scars, Striae | 14 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01810484) |
| December 24, 2012 | NCT01756027 | Feasibility Study: Ulthera System for the Treatment of Rosacea | Ulthera, Inc | Not applicable | Completed | Erythematotelangiectatic Rosacea | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01756027) |
| November 6, 2012 | NCT01722461 | A Study of the Ulthera® System for the Treatment of Axillary Hyperhidrosis | Ulthera, Inc | Not applicable | Terminated | Primary Axillary Hyperhidrosis | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01722461) |
| October 25, 2012 | NCT01713998 | Treatment of the Face and Neck With Lower Ulthera System Energy Settings | Ulthera, Inc | Not applicable | Completed | Skin Laxity | 47 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01713998) |
| October 25, 2012 | NCT01713985 | Feasibility Study: Evaluation of Ulthera Versus Thermage for Treating the Face and Neck | Ulthera, Inc | Not applicable | Completed | Skin Laxity, Wrinkles | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01713985) |
| October 25, 2012 | NCT01713959 | Feasibility Study: Ulthera® System for the Treatment of Axillary Hyperhidrosis | Ulthera, Inc | Not applicable | Completed | Hyperhidrosis | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01713959) |
| October 25, 2012 | NCT01713933 | Evaluation of the Ulthera® System for Treatment of the Brachia | Ulthera, Inc | Not applicable | Completed | Brachial Ptosis | 37 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01713933) |
| October 25, 2012 | NCT01713907 | Evaluation of the Ulthera® System for Treatment of the Face and Neck | Ulthera, Inc | Not applicable | Terminated | Wrinkles, Rhytids, Skin Laxity | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01713907) |
| October 25, 2012 | NCT01713686 | Evaluation of the Ulthera System for the Treatment of the Decolletage | Ulthera, Inc | Not applicable | Completed | Chest Wrinkles | 129 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01713686) |
| October 25, 2012 | NCT01713673 | Feasibility Study: Safety and Efficacy of the Ulthera® System for Treatment of Axillary Hyperhidrosis | Ulthera, Inc | Not applicable | Completed | Hyperhidrosis | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01713673) |
| October 24, 2012 | NCT01713569 | Feasibility Study: Histological Characterization After Treatment With the Ulthera® System | Ulthera, Inc | Not applicable | Terminated | Skin Laxity | 2 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01713569) |

## By phase

| Phase | Trials |
| --- | --- |
| Not applicable | 44 |
| Observational | 2 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 39 |
| Terminated | 7 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Cutis Laxa | 21 |
| Hyperhidrosis | 3 |
| Facies | 2 |
| Rosacea | 2 |
| Cicatrix | 2 |
| Telangiectasis | 1 |
| Striae Distensae | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Investment management firms in the United States](https://specstream.ai/data/businesses/investment-management-firms/united-states)
- [B2B advertising and marketing companies in the United States](https://specstream.ai/data/businesses/b2b-advertising-and-marketing-companies/united-states)
- [Metal suppliers in the United States](https://specstream.ai/data/businesses/metal-suppliers/united-states)
- [Business banking companies in the United States](https://specstream.ai/data/businesses/business-banking-companies/united-states)
- [Pharmaceutical products wholesalers in the United States](https://specstream.ai/data/businesses/pharmaceutical-products-wholesalers/united-states)
- [Credit and debt counseling services in the United States](https://specstream.ai/data/businesses/credit-and-debt-counseling-services/united-states)
